COVID-19 Research Paper Volume 13, Issue 12 pp 15785—15800
Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease
Figure 4. Gene network analysis of vitamin A against CHOL/COVID-19. (A) STRING analysis indicated protein-protein interaction mediated by 9 intersecting genes of VA against CHOL/COVID-19. (B) Cytoscape analysis further showed the involvement of 6 core candidates including CAT, NOS2, CXCR3, MAPK1, GPT, and ICAM1 in protein interaction network related to action of VA against CHOL/COVID-19.